Related Experiment Videos
Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic
J Eric Jensen1, Blaise de B Frederick, Perry F Renshaw
1Brain Imaging Center, McLean Hospital, Belmont, MA 02478-9106, USA.
NMR in Biomedicine
|November 8, 2005
Summary
This study found higher levels of gamma-aminobutyric acid (GABA) in human cortical grey matter compared to white matter using advanced imaging. This neurochemical difference has implications for understanding brain conditions.
Area of Science:
- Neuroimaging
- Neurochemistry
- Magnetic Resonance Spectroscopy
Background:
- Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain.
- Previous studies suggest regional differences in brain GABA concentrations, but in vivo quantification remains challenging.
Purpose of the Study:
- To quantify in vivo differences in GABA levels between cortical grey matter and white matter.
- To validate a novel 2D J-resolved chemical-shift imaging sequence for neurochemical analysis.
Main Methods:
- A novel 2D J-resolved chemical-shift imaging sequence was employed at 4 Tesla.
- Data from six healthy subjects were analyzed using image segmentation and linear regression.
- Brain GABA levels were correlated with tissue type (grey matter vs. white matter).
Main Results:
- A significant elevation of mean GABA levels was observed in cortical grey matter (0.96 ± 0.24 mM) compared to white matter (0.44 ± 0.16 mM) across all subjects (p < 0.01).
- Results indicate an approximate two-fold higher concentration of GABA in grey matter versus white matter in vivo.
- Findings align with established ex vivo studies.
Conclusions:
- The developed spectroscopic imaging technique successfully quantifies tissue-specific GABA levels in vivo.
- Demonstrates significantly higher GABA concentrations in cortical grey matter compared to white matter.
- Highlights the potential of this method for detecting neurochemical alterations in neurological disorders.